Fecal microbiota-based treatment for recurrent Clostridioides difficile infection

被引：20
|
作者：
Walter, Jens [1 ,2 ,3 ]
Shanahan, Fergus [1 ,2 ]
机构：
[1] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland
[2] Univ Coll Cork, Dept Med, Cork, Ireland
[3] Univ Coll Cork, Sch Microbiol, Cork, Ireland
来源：
CELL | 2023年 / 186卷 / 06期
关键词：
D O I：
10.1016/j.cell.2023.02.034
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1087 / 1087
页数：1
相关论文
共 50 条
  • [1] Fecal microbiota for recurrent Clostridioides difficile infection
    Venkatesan, Priya
    LANCET INFECTIOUS DISEASES, 2025, 25 (04): : e211 - e211
  • [2] Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
    Chopra, Teena
    Hecht, Gail
    Tillotson, Glenn
    FRONTIERS IN MEDICINE, 2023, 9
  • [3] Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection
    Stallhofer, Johannes
    Steube, Arndt
    Katzer, Katrin
    Stallmach, Andreas
    VISCERAL MEDICINE, 2024, 40 (02) : 82 - 91
  • [4] Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection
    Voth, Elida
    Khanna, Sahil
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (07) : 669 - 676
  • [5] Fecal microbiota transplantation for recurrent Clostridioides difficile infection
    Haber, Stacy L.
    Raney, Carrington R. K.
    Larson, Trent L.
    Lau, Jennifer Park
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (13) : 935 - 942
  • [6] Microbiota-based markers predictive of development of Clostridioides difficile infection
    Berkell, Matilda
    Mysara, Mohamed
    Xavier, Basil Britto
    van Werkhoven, Cornelis H.
    Monsieurs, Pieter
    Lammens, Christine
    Ducher, Annie
    Vehreschild, Maria J. G. T.
    Goossens, Herman
    de Gunzburg, Jean
    Bonten, Marc J. M.
    Malhotra-Kumar, Surbhi
    Engbers, Annemarie
    de Regt, Marieke
    Biehl, Lena M.
    Cornely, Oliver A.
    Jazmati, Nathalie
    Bouverne, Marie-Noelle
    Sablier-Gallis, Frederique
    Mentre, France
    Merle, Uta
    Stallmach, Andreas
    Rupp, Jan
    Bogner, Johannes
    Lubbert, Christoph
    Silling, Gerda
    Witzke, Oliver
    Gikas, Achilleas
    Maraki, Sofia
    Daikos, George
    Tsiodras, Sotirios
    Skoutelis, Athanasios
    Sambatakou, Helen
    Pujol, Miguel
    Dominguez-Luzon, M. Angeles
    Aguado, Jose M.
    Bouza, Emilio
    Cobo, Javier
    Rodriguez-Bano, Jesus
    Almirante, Benito
    Cisneros, Julian de la Torre
    Florescu, Simin A.
    Nica, Maria
    Vata, Andrei
    Hristea, Adriana
    Lupse, Mihaela
    Herghea, Delia
    Postil, Deborah
    Barraud, Olivier
    Molina, Jean-Michel
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [7] Microbiota-based markers predictive of development of Clostridioides difficile infection
    Matilda Berkell
    Mohamed Mysara
    Basil Britto Xavier
    Cornelis H. van Werkhoven
    Pieter Monsieurs
    Christine Lammens
    Annie Ducher
    Maria J. G. T. Vehreschild
    Herman Goossens
    Jean de Gunzburg
    Marc J. M. Bonten
    Surbhi Malhotra-Kumar
    Nature Communications, 12
  • [8] Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)
    Minkoff, Nathan Zev
    Aslam, Scheherzade
    Medina, Melissa
    Tanner-Smith, Emily E.
    Zackular, Joseph P.
    Acra, Sari
    Nicholson, Maribeth R.
    Imdad, Aamer
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (04):
  • [9] Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent Clostridioides difficile Infection
    Papazyan, Romeo
    Ferdyan, Nicky
    Srinivasan, Karthik
    Gonzalez, Carlos
    Shannon, William D.
    Blount, Ken
    Fuchs, Bryan C.
    MICROORGANISMS, 2023, 11 (01)
  • [10] Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
    Carlucci, Christian
    Petrof, Elaine O.
    Allen-Vercoe, Emma
    EBIOMEDICINE, 2016, 13 : 37 - 45
12345